NEW YORK CITY-Global biotech firm Genencor International Inc. will spend up to $50 million on a biologics manufacturing facility for clinical trials of drug candidates.

The 20,000-sf building will be located in Rochester, the firm’s business operations headquarters city, and its performance will help company officials decide whether to further expand its Rochester operation. Genencor says it will retain all 200 of its Rochester employees and that the new health care business unit facility will create up to 100 high-tech sector jobs.

The facility, which must meet FDA requirements, is expected to be operational in two years. Possible future plans may include the development of commercial manufacturing and the potential for up to 500 new jobs.

“We could have sited this new facility in other areas of the US or abroad, but decided that New York State would be the best place for us to focus our future in the burgeoning human health care business,” says Carole Cobb, senior vice president of global manufacturing for Genencor.

The company is eligible to receive Empire Zone benefits based on its investments and job creation. It may also apply for a $550,000 capital grant from Empire State Development.

Genencor is the latest biotech company to take advantage of New York hospitality. Sear Brown, also of Rochester, recently chose three New York State locations–Albany, Binghamton and Melville–to create Design Centers of Excellence in Biotechnology.

In February, Pataki revealed the establishment of the Cornell Agriculture and Food Technology Park in Geneva. In addition, Bristol-Myers Squibb has established its Center for Biotechnology Development in Syracuse.

Genencor develops biotechnology products for the health care, agri-processing and specialty chemicals markets. The firm maintains its corporate and R&D headquarters in Palo Alto, CA and has manufacturing facilities throughout the world.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

GlobeSt Net Lease Spring 2024Event

This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.

Get More Information
 

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.